Compound 2013
Identifiers
- Canonical SMILES:
CC(=NNC(=O)c1ccccc1O)c1ccc2ccccc2c1O
- IUPAC name:
2-hydroxy-N'-[1-(1-hydroxynaphthalen-2-yl)ethylidene]benzohydrazide
- InChi:
InChI=1S/C19H16N2O3/c1-12(20-21-19(24)16-8-4-5-9-17(16)22)14-11-10-13-6-2-3-7-15(13)18(14)23/h2-11,22-23H,1H3,(H,21,24)
- InChiKey:
LJGDTCIGYKNKQN-UHFFFAOYSA-N
External links
![]() 689179 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
PCNA trimer | 6.15 | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 320.12 g/mol | |||
HBA | 5 | |||
HBD | 3 | |||
HBA + HBD | 8 | |||
AlogP | 3.84 | |||
TPSA | 81.92 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1124/mol.112.077735 | PCNA-I9 | PCNA P12004 |
|
Cellular assay | cell growth inhibition PC-3 | PC-3 | pIC50 (half maximal inhibitory concentration, -log10) | 5.66 |
10.1124/mol.112.077735 | PCNA-I9 | PCNA P12004 |
|
Cellular assay | cell growth inhibition LNCaP | LNCaP | pIC50 (half maximal inhibitory concentration, -log10) | 6.15 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7419 | 4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07097 | |
0.7253 | N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide | DB06949 | |
0.7174 | (E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE | DB08034 | |
0.6915 | 3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07044 | |
0.6915 | 4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB07098 | |
0.6600 | 4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide | DB06950 | |
0.6566 | N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide | DB06978 | |
0.5546 | PAC-1 | DB13048 | |
0.5431 | N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE | DB07445 | |
0.5058 | 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE | DB06884 | |
0.4533 | Salicylamide | DB08797 | |
0.4337 | Benmoxin | DB09246 | |
0.4316 | Nifuroxazide | DB13855 | |
0.4266 | 3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol | DB03996 | |
0.4250 | Trencam-3,2-Hopo | DB04476 |